Cold antibody autoimmune hemolytic anemias

Area of Science:

• Hematology
• Immunology
• Internal Medicine

Background:

• Cold antibody autoimmune hemolytic anemias (AIHAs) encompass cold agglutinin syndrome (CAS) and paroxysmal cold hemoglobinuria (PCH).
• Mixed AIHA, presenting features of both warm and cold AIHA, is also recognized.
• CAS affects older adults, triggered by cold, involving IgM antibodies reactive at low temperatures.

Purpose of the Study:

• To delineate the characteristics of cold antibody autoimmune hemolytic anemias.
• To differentiate between CAS and PCH based on serologic and clinical features.
• To review current and emerging therapeutic strategies for these conditions.

Main Methods:

• Review of existing literature on CAS and PCH.
• Analysis of serologic criteria for diagnosis.
• Examination of clinical presentations and treatment outcomes.

Main Results:

• CAS involves IgM antibodies, often refractory to treatment, with rituximab showing promise.
• PCH, common in children post-infection, involves IgG biphasic hemolysins, typically self-resolving.
• Treatment for PCH is supportive, often requiring transfusions for acute attacks.

Conclusions:

• CAS and PCH are distinct cold AIHA subtypes with differing demographics, antibodies, and prognoses.
• Effective management requires accurate diagnosis and tailored therapeutic approaches.
• Further research into novel treatments for refractory CAS is warranted.